润都股份(002923.SZ)：坎地沙坦酯片获得药品注册证书

Core Viewpoint - Rundu Co., Ltd. has received the drug registration certificate for Candesartan Cilexetil Tablets from the National Medical Products Administration, indicating the product's approval for the treatment of primary hypertension [1] Company Summary - Rundu Co., Ltd. is now authorized to market Candesartan Cilexetil Tablets, which are specifically indicated for primary hypertension [1]